2,6-Difluoroiodobenzene - CAS 13697-89-7
Catalog: |
BB008488 |
Product Name: |
2,6-Difluoroiodobenzene |
CAS: |
13697-89-7 |
Synonyms: |
1,3-difluoro-2-iodobenzene; 1,3-difluoro-2-iodobenzene |
IUPAC Name: | 1,3-difluoro-2-iodobenzene |
Description: | 2,6-Difluoroiodobenzene (CAS# 13697-89-7) is a useful research chemical. |
Molecular Weight: | 239.99 |
Molecular Formula: | C6H3F2I |
Canonical SMILES: | C1=CC(=C(C(=C1)F)I)F |
InChI: | InChI=1S/C6H3F2I/c7-4-2-1-3-5(8)6(4)9/h1-3H |
InChI Key: | VQMXWPLTZBKNEH-UHFFFAOYSA-N |
Boiling Point: | 186.1 °C at 760 mmHg |
Density: | 2.001 g/cm3 |
Storage: | Keep in dark place, Sealed in dry, Room Temperature |
MDL: | MFCD04039247 |
LogP: | 2.56940 |
GHS Hazard Statement: | H227 (33.33%): Combustible liquid [Warning Flammable liquids] |
Precautionary Statement: | P210, P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P370+P378, P403+P233, P403+P235, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-111440137-A | 3, 4-benzocoumarin derivative and preparation method and application thereof | 20200428 |
US-2021205311-A1 | Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors | 20200103 |
US-2021230294-A1 | Cd73 inhibitor and a2a/a2b adenosine receptor inhibitor combination therapy | 20200103 |
WO-2021138512-A1 | Combination therapy comprising a2a/a2b and pd-1/pd-l1 inhibitors | 20200103 |
CN-110903311-A | Polycyclic organoboron derivatives and electronic devices | 20191120 |
PMID | Publication Date | Title | Journal |
19851571 | 20091114 | Laser-induced 3D alignment and orientation of quantum state-selected molecules | Physical chemistry chemical physics : PCCP |
Complexity: | 87.1 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 239.92475 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 239.92475 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 0 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.8 |
-
Catalog: BB045655
((5-[(4-Chloro-3-methyl-1H-pyrazol-1-yl)methyl]-4-ethyl-4H-1,2,4-triazol-3-yl)thio)acetic acid
Detail
-
Catalog: BB025409
(1-Bromo-2,2,2-trifluoroethyl)benzene
Detail
-
Catalog: BB035854
(1-Bromocyclopropyl)benzene
Detail
-
Catalog: BB044157
(+)-2,10-(3,3-dichlorocamphorsultam)
Detail
-
Catalog: BB054190
(-)-(8,8-Dichlorocamphorylsulfonyl)oxaziridine
Detail
-
Catalog: BB054256
((2S,4R)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methanol
Detail
-
Catalog: BB051699
(1-(2,2-Difluoroethyl)-1H-pyrazol-4-yl)methanamine hydrochloride
Detail
-
Catalog: BB078021
(1-(3-Bromo-5-fluorophenyl)cyclopropyl)methanamine
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Halides
Customers Also Viewed
-
[711-38-6]
2,2,2-Trifluoro-4'-methoxyacetophenone
-
[84249-14-9]
2-Amino-4-bromopyridine
-
[133407-82-6]
MG-132
-
[34374-88-4]
2,4,6-Trihydroxybenzene-1,3,5-tricarbaldehyde
-
[94242-51-0]
1-Cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester
-
[1393527-23-5]
Phosphoric acid 6,6'-di(9-anthryl)-1,1'-spirobiindan-7,7'-diyl ester
INDUSTRY LEADERS TRUST OUR PRODUCTS